{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:06:32Z","timestamp":1773392792988,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1076,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["R41 DK092105"],"award-info":[{"award-number":["R41 DK092105"]}]},{"name":"NIH","award":["EB001981"],"award-info":[{"award-number":["EB001981"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajp.amjpathol.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ajpath.2016.09.013","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T02:15:20Z","timestamp":1479176120000},"page":"33-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Chronic Phenotype Characterization of a Large-Animal Model of Hereditary Tyrosinemia Type 1"],"prefix":"10.1016","volume":"187","author":[{"given":"Faysal","family":"Elgilani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shennen A.","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime M.","family":"Glorioso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ianko D.","family":"Iankov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anisha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Amiot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Rinaldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J.","family":"Marler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard L.","family":"Ehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Grompe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph B.","family":"Lillegard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond D.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott L.","family":"Nyberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2016.09.013_bib1","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1073\/pnas.74.10.4641","article-title":"On the enzymic defects in hereditary tyrosinemia","volume":"74","author":"Lindblad","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2016.09.013_bib2","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/0006-291X(92)91853-I","article-title":"\u201cOxidative stress\u201d response in liver of an untreated newborn mouse having a 1.2-centimorgan deletion on chromosome 7","volume":"182","author":"Liang","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2016.09.013_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/bbrc.1997.6220","article-title":"The mutagenicity of the tyrosine metabolite, fumarylacetoacetate, is enhanced by glutathione depletion","volume":"232","author":"Jorquera","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2016.09.013_bib4","doi-asserted-by":"crossref","first-page":"11928","DOI":"10.1073\/pnas.96.21.11928","article-title":"In\u00a0vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I","volume":"96","author":"Manning","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2016.09.013_bib5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0140-6736(92)92685-9","article-title":"Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase","volume":"340","author":"Lindstedt","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2016.09.013_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2012.05.022","article-title":"Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Quebec","volume":"107","author":"Larochelle","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ajpath.2016.09.013_bib7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10545-014-9683-x","article-title":"Early nitisinone treatment reduces the need for liver transplantation in children with tyrosinaemia type 1 and improves post-transplant renal function","volume":"37","author":"Bartlett","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ajpath.2016.09.013_bib8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2165\/00003495-200666060-00002","article-title":"Nitisinone in the treatment of hereditary tyrosinaemia type 1","volume":"66","author":"McKiernan","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.ajpath.2016.09.013_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0092-8674(79)90001-1","article-title":"Genetic control of morphogenetic and biochemical differentiation: lethal albino deletions in the mouse","volume":"16","author":"Gluecksohn-Waelsch","year":"1979","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2016.09.013_bib10","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1101\/gad.7.12a.2298","article-title":"Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice","volume":"7","author":"Grompe","year":"1993","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajpath.2016.09.013_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/mgme.2001.3266","article-title":"Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I","volume":"75","author":"Al-Dhalimy","year":"2002","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ajpath.2016.09.013_bib12","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.bbadis.2015.09.002","article-title":"Molecular changes associated with chronic liver damage and neoplastic lesions in a murine model of hereditary tyrosinemia type 1","volume":"1852","author":"Angileri","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ajpath.2016.09.013_bib13","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/hep.24490","article-title":"Efficient production of Fah-null heterozygote pigs by chimeric adeno-associated virus-mediated gene knockout and somatic cell nuclear transfer","volume":"54","author":"Hickey","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2016.09.013_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.scr.2014.05.003","article-title":"Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease","volume":"13","author":"Hickey","year":"2014","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.ajpath.2016.09.013_bib15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00109-010-0610-9","article-title":"Transgenic pigs as models for translational biomedical research","volume":"88","author":"Aigner","year":"2010","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.ajpath.2016.09.013_bib16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/prca.201300099","article-title":"The pig as an animal model for human pathologies: a proteomics perspective","volume":"8","author":"Bassols","year":"2014","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.ajpath.2016.09.013_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1146\/annurev.med.53.082901.103900","article-title":"Will the pig solve the transplantation backlog?","volume":"53","author":"Cooper","year":"2002","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ajpath.2016.09.013_bib18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1373\/clinchem.2007.101949","article-title":"Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots","volume":"54","author":"Turgeon","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajpath.2016.09.013_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1361-8415(00)00039-6","article-title":"Magnetic resonance elastography: non-invasive mapping of tissue elasticity","volume":"5","author":"Manduca","year":"2001","journal-title":"Med Image Anal"},{"key":"10.1016\/j.ajpath.2016.09.013_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0002-9440(10)64212-5","article-title":"Kinetics of liver repopulation after bone marrow transplantation","volume":"161","author":"Wang","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2016.09.013_bib21","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/jmri.24189","article-title":"Evaluation of liver fibrosis and hepatic venous pressure gradient with MR elastography in a novel swine model of cirrhosis","volume":"39","author":"Huang","year":"2014","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.ajpath.2016.09.013_bib22","unstructured":"Sniderman King L, Trahms C, Scott CR: Tyrosinemia type I. Edited by Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K. In GeneReviews [Internet]. Copyright University of Washington, Seattle. 1993. Available at https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1515. (last revised July 17, 2014)."},{"key":"10.1016\/j.ajpath.2016.09.013_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13023-014-0107-7","article-title":"Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice","volume":"9","author":"Mayorandan","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ajpath.2016.09.013_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s100240010146","article-title":"Tyrosinemia: a review","volume":"4","author":"Russo","year":"2001","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.ajpath.2016.09.013_bib25","first-page":"726","article-title":"Diagnosis and management of tyrosinemia type I","volume":"7","author":"Holme","year":"1995","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.ajpath.2016.09.013_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/taap.1995.1121","article-title":"Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dione","volume":"133","author":"Ellis","year":"1995","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.ajpath.2016.09.013_bib27","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cgh.2007.06.012","article-title":"Assessment of hepatic fibrosis with magnetic resonance elastography","volume":"5","author":"Yin","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2016.09.013_bib28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/mrm.21286","article-title":"Quantitative assessment of hepatic fibrosis in an animal model with magnetic resonance elastography","volume":"58","author":"Yin","year":"2007","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.ajpath.2016.09.013_bib29","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1148\/radiol.2452061673","article-title":"Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index","volume":"245","author":"Huwart","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.ajpath.2016.09.013_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jmri.22610","article-title":"Portal hypertension correlates with splenic stiffness as measured with MR elastography","volume":"34","author":"Nedredal","year":"2011","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.ajpath.2016.09.013_bib31","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/jmri.24049","article-title":"Hepatic and splenic stiffness augmentation assessed with MR elastography in an in\u00a0vivo porcine portal hypertension model","volume":"38","author":"Yin","year":"2013","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.ajpath.2016.09.013_bib32","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/jmri.24248","article-title":"Liver dynamic contrast-enhanced MRI for staging liver fibrosis in a piglet model","volume":"39","author":"Zhou","year":"2014","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.ajpath.2016.09.013_bib33","doi-asserted-by":"crossref","first-page":"349ra99","DOI":"10.1126\/scitranslmed.aaf3838","article-title":"Curative ex\u00a0vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1","volume":"8","author":"Hickey","year":"2016","journal-title":"Sci Transl Med"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944016304175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944016304175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:38:47Z","timestamp":1634517527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944016304175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0002944016304175"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2016.09.013","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Phenotype Characterization of a Large-Animal Model of Hereditary Tyrosinemia Type 1","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2016.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}